Free tool

Oncology stocks

We cover 14 companies grouped under the Oncology theme. The median market value in the group is $148.69M. Across the group, the median move over the past trading day is −0.79%. Price change over the past year runs from −69.0% to +249.0% across the middle 80 percent of the group, with a median of −17.8%.

Other lists in this group

Table

14 of 319 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y returnNext report
SMMTSummit Therapeutics Inc.$10.66BLarge cap−49.14%Oct 19, 2026
0QAV.LNanobiotix S.A.$671.98MSmall cap+346.30%Sep 29, 2026
PRTC.LPureTech Health plc$402.61MSmall cap−11.34%Aug 27, 2026
IPHAInnate Pharma S.A.$253.56MSmall cap+1.34%Sep 17, 2026
IDD.DEInnate Pharma S.A.$247.30MSmall cap−2.52%Sep 17, 2026
IPH.PAInnate Pharma S.A.$244.95MSmall cap+1.84%Sep 17, 2026
BINV.STBioInvent International AB (publ)$169.15MSmall cap−24.30%Aug 27, 2026
0RU5.LOncoinvent ASA$128.23MSmall cap+5951.72%Aug 27, 2026
ANIXAnixa Biosciences, Inc.$123.16MSmall cap+22.00%Sep 9, 2026
OSE.PAOSE Immunotherapeutics SA$88.77MMicro cap−47.82%Sep 28, 2026
IMMPImmutep Limited$56.28MMicro cap−77.54%Sep 2, 2026
0RAD.LOSE Immunotherapeutics SA$51.87MMicro cap−48.92%Sep 28, 2026
BLRXBioLineRx Ltd.$12.45MMicro cap−25.97%Aug 31, 2026
LNAILunai Bioworks Inc.$9.97MMicro cap−87.99%Sep 28, 2026

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse